Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


SeongRyeol Moon has a total of 17 co-authors. Here are the top co-authors by number of shared publications:

  • Seungyoon Nam

    Department of Genome Medicine and Science, Gachon Institute of Genome Medicine and Science, Gachon University Gil Medical Center, Gachon University College of Medicine, Incheon, Republic of Korea

    3 shared publications
  • Dae Ho Lee

    Department of Internal Medicine, Gachon University Gil Medical Center, Incheon 21565, Korea

    1 shared publication
  • Hee Joo Kim

    Department of Dermatology, Gachon University Gil Medical Center, Gachon University College of Medicine, Incheon, 21565, South Korea

    1 shared publication
  • Hyo Jin Eom

    Research and Development Department, Corestem Inc., Seongnam 13486, Korea

    1 shared publication
  • Ie Byung Park

    Division of Endocrinology and Metabolism, Department of Internal Medicine Gachon University Gil Medical Center Incheon South Korea

    1 shared publication
  • Jin Sook Lee

    Department of Genome Medicine and Science, Gachon Institute of Genome Medicine and Science, Gachon University Gil Medical Center, Gachon University College of Medicine, Incheon, 21565, South Korea; Department of Pediatrics, Seoul National University Hospital Child Cancer and Rare Disease Administration, Seoul National University Children's Hospital, Seoul, 03080, South Korea

    1 shared publication

Latest Publications

  • Oncogenic signaling pathways and hallmarks of cancer in Korean patients with acral melanoma

    by SeongRyeol Moon, Hee Joo Kim, Yeeun Lee, Yu Joo Lee, Sungwon Jung, Jin Sook Lee, Si Houn Hahn, Kyungdoc Kim, Joo Young Roh, Seungyoon Nam


  • Open Access

    High Expression of PRNP Predicts Poor Prognosis in Korean Patients with Gastric Cancer

    by Minseok Choi, SeongRyeol Moon, Hyo Jin Eom, Seung Mook Lim, Yon Hui Kim, Seungyoon Nam

    Gastric cancer (GC) has the highest occurrence and fourth-highest mortality rate of all cancers in Korea. Although survival rates are improving with the development of diagnosis and treatment methods, the five-year survival rate for stage 4 GC in Korea remains PRNP is a gene encoding the prion protein PrP, which has been noted for its role in the nervous system and is known to be upregulated in various cancers and associated with both cell proliferation and metastasis. However, the value of PRNP as a prognostic factor for Korean GC patients remains unclear. Here, we analyzed the relationship between PRNP expression and survival in three independent datasets for Korean patients with GC as well as the TCGA-STAD dataset. Survival analysis indicates that high levels of PRNP expression are associated with poor overall survival of patients with GC. Gene set enrichment analysis showed that PRNP is associated with epithelial mesenchymal transition and Hedgehog signaling. In addition, proliferation of GC cell lines was inhibited after siRNA-mediated knockdown of PRNP. In conclusion, our study suggests a potential role for PRNP as a candidate prognostic factor for patients with GC.


  • Open Access

    miR2Diabetes: A Literature-Curated Database of microRNA Expression Patterns, in Diabetic Microvascular Complications

    by Sungjin Park, SeongRyeol Moon, Kiyoung Lee, Ie Byung Park, Dae Ho Lee, Seungyoon Nam

    MicroRNAs (miRNAs) have been established as critical regulators of the pathogenesis of diabetes mellitus (DM), and diabetes microvascular complications (DMCs). However, manually curated databases for miRNAs, and DM (including DMCs) association studies, have yet to be established. Here, we constructed a user-friendly database, “miR2Diabetes,” equipped with a graphical web interface for simple browsing or searching manually curated annotations. The annotations in our database cover 14 DM and DMC phenotypes, involving 156 miRNAs, by browsing diverse sample origins (e.g., blood, kidney, liver, and other tissues). Additionally, we provide miRNA annotations for disease-model organisms (including rats and mice), of DM and DMCs, for the purpose of improving knowledge of the biological complexity of these pathologies. We assert that our database will be a comprehensive resource for miRNA biomarker studies, as well as for prioritizing miRNAs for functional validation, in DM and DMCs, with likely extension to other diseases.